Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1999 2
2002 1
2004 3
2005 1
2006 4
2007 5
2008 9
2009 12
2010 10
2011 2
2012 12
2013 20
2014 21
2015 15
2016 6
2017 5
2018 5
2019 8
2020 10
2021 6
2022 8
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18447593

144 results

Results by year

Filters applied: . Clear all
Page 1
Pituitary-targeted medical therapy of Cushing's disease.
Alexandraki KI, Grossman AB. Alexandraki KI, et al. Expert Opin Investig Drugs. 2008 May;17(5):669-77. doi: 10.1517/13543784.17.5.669. Expert Opin Investig Drugs. 2008. PMID: 18447593 Review.
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J. Boscaro M, et al. J Clin Endocrinol Metab. 2009 Jan;94(1):115-22. doi: 10.1210/jc.2008-1008. Epub 2008 Oct 28. J Clin Endocrinol Metab. 2009. PMID: 18957506 Clinical Trial.
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW. Feelders RA, et al. N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094. N Engl J Med. 2010. PMID: 20463350 Clinical Trial. No abstract available.
Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
van der Pas R, Feelders RA, Gatto F, de Bruin C, Pereira AM, van Koetsveld PM, Sprij-Mooij DM, Waaijers AM, Dogan F, Schulz S, Kros JM, Lamberts SW, Hofland LJ. van der Pas R, et al. J Clin Endocrinol Metab. 2013 Dec;98(12):E1880-90. doi: 10.1210/jc.2013-1987. Epub 2013 Sep 30. J Clin Endocrinol Metab. 2013. PMID: 24081741
Update in the medical therapy of Cushing's disease.
Nieman LK. Nieman LK. Curr Opin Endocrinol Diabetes Obes. 2013 Aug;20(4):330-4. doi: 10.1097/MED.0b013e3283631809. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 23807605 Free PMC article. Review.
144 results